Screening for mucopolysaccharidoses in the Turkish population: Analytical and clinical performance of an age-range specific, dye-based, urinary glycosaminoglycan assay

Creative Commons License

EL MOUSTAFA K., Sivri S., KARAHAN S. , COŞKUN T. , Akblyik F., LAY İ.

CLINICA CHIMICA ACTA, vol.464, pp.72-78, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 464
  • Publication Date: 2017
  • Doi Number: 10.1016/j.cca.2016.11.015
  • Title of Journal : CLINICA CHIMICA ACTA
  • Page Numbers: pp.72-78


Comprehensive analytical and diagnostic performance of urinary quantitative GAG analysis with dimethylmethylene blue (DMB) and the age-specific reference ranges were determined in Turkish population, which has a high incidence of MPSs. Precision, linearity, recovery and accuracy/trueness, limits, stability, and effect of interferents were tested according to CLSI guideline. Clinical performance was evaluated with ROC analyses including 45 MPS patients. Intra-day and inter-day precisions were <5% and <11% (CV), respectively. LoD was 9.12 mg/L and LoQwas 23.3 mg/L. The highest reference values for urinary GAG excretion were determined in an age-specific manner. In the 2-13 years age cohort, a cut-off of 89.86 mg/g creatinine resulted in 98.07% sensitivity and 93.33% specificity. Proteinuria and hematuria interfered with analysis in some instances. Neither leukocyturia nor pH changes affected the assay. Stability analysis indicated that freezing urine samples for transfer is unnecessary. Of the 45 MPS patient samples evaluated, only three tested negative including MPS II, IVA and VI. Despite limitations due to low levels of urinary GAG excretion in some cases, urinary GAG analysis with DMB with its technical simplicity, low cost, and precise quantitative results, is a valuable screening method, particularly in populations with a high rate of MPSs. (C) 2016 Elsevier B.V. All rights reserved.